v3.26.3
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2026
Summary of Significant Accounting Policies [Line Items]  
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following table represents the Company’s fair value hierarchy of its financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025.

 

    September 30, 2026     December 31, 2025  
Description   Level 1     Level 2     Level 3     Level 1     Level 2     Level 3  
Short-term investments   $ 11,402,526     $ -     $ -     $ 11,345,187     $ -     $ -  
Non-traded equity securities   $ -     $ -     $ 25,000     $ -     $ -     $ 180,000  
Schedule of Revenue

During the three and nine months ended September 30, 2026 and 2025, revenues consisted of the following:

 

    For the
Three Months Ended
September 30,		     For the
Nine Months Ended
September 30,		  
    2026     2025     2026     2025  
Revenue from administrative services   $ 1,958,620     $ 441,227     $ 4,941,581     $ 634,177  
Revenue from the sale of health coaching packages     -       -       -       1,124  
Revenue from the sale of subscriptions     855,907       57,042       2,139,670       57,648  
Revenue from sale of in-game items     -       2       -       25  
Total revenues   $ 2,814,527     $ 498,271     $ 7,081,251     $ 692,974  
Schedule of Deferred Revenue

For the nine months ended September 30, 2026 and 2025, deferred revenue activity consisted of the following:

 

    For the
Nine Months
Ended
September 30,
2026		     For the
Nine Months
Ended
September 30,
2025		  
Balance – beginning of period   $ 130,054     $ 1,126  
Additions     424,370       26,957  
Recognized as revenue     (130,054 )     (1,126 )
Balance – end of period   $ 424,370     $ 26,957  
Schedule of Common Stock Equivalents Excluded from Computation of Diluted Shares Outstanding

During the three and nine months ended September 30, 2026 and 2025, the following common stock equivalents were excluded from the computation of diluted shares outstanding as they would have had an anti-dilutive impact on the Company’s net loss.

 

    September 30,  
    2026     2025  
Common stock equivalents:                
Warrants     7,667,296       4,509,259  
Stock options     284,084       139,084  
Total     7,951,380       4,648,343  
Equity Securities [Member]  
Summary of Significant Accounting Policies [Line Items]  
Schedule of Investment in Non-Traded Equity Securities

The following table summarizes activity in the Company’s investment in non-traded equity securities, at fair value for the periods presented:

 

    Nine Months
Ended
September 30,		     Nine Months
Ended
September 30,		  
    2026     2025  
Balance, beginning of period   $ 180,000     $ 199,998  
Unrealized loss on non-traded equity securities     (155,000 )     -  
Balance, end of period   $ 25,000     $ 199,998